PRESS RELEASE published on 11/28/2025 at 13:10, 3 months 25 days ago Xlife Sciences AG Provides Update on VERAXA Biotech AG’s NASDAQ Listing Process Following U.S. Government Shutdown Xlife Sciences AG updates on VERAXA Biotech AG's NASDAQ listing process post U.S. Government Shutdown, SEC responds to Form F-4 filing, progress towards business combination with Voyager Acquisition Corp Nasdaq SEC Xlife Sciences AG VERAXA Biotech AG Voyager Acquisition Corp.
BRIEF published on 10/16/2025 at 07:05, 5 months 8 days ago Xlife Sciences AG publie son rapport ESG 2024 mettant en avant la croissance durable Croissance Durable Responsabilité Sociale Impact Environnemental Xlife Sciences Rapport ESG 2024
BRIEF published on 10/16/2025 at 07:05, 5 months 8 days ago Xlife Sciences AG Releases 2024 ESG Report Highlighting Sustainable Growth Environmental Impact Social Responsibility Sustainable Growth Xlife Sciences ESG Report 2024
PRESS RELEASE published on 10/16/2025 at 07:00, 5 months 8 days ago Xlife Sciences AG Publishes 2024 ESG Report: Sustainable Value Creation as a Strategic Core Xlife Sciences AG publishes 2024 ESG Report showcasing sustainable value creation through integrating ESG principles into corporate strategy and portfolio management in life sciences sector Life Sciences Xlife Sciences AG ESG Principles Sustainable Value Creation 2024 ESG Report
BRIEF published on 09/23/2025 at 07:05, 6 months 1 day ago Xlife Sciences AG Focuses on VERAXA's NASDAQ Listing in H1 2025 Financial Performance Nasdaq Listing Global Partnerships Xlife Sciences Biotech Expansion
BRIEF published on 09/23/2025 at 07:05, 6 months 1 day ago Xlife Sciences AG se concentre sur l'introduction de VERAXA au NASDAQ au premier semestre 2025 Performance Financière Partenariats Mondiaux Xlife Sciences Cotation Au Nasdaq Expansion Biotechnologique
PRESS RELEASE published on 09/23/2025 at 07:00, 6 months 1 day ago Xlife Sciences AG Half-Year Report 2025: Focus on VERAXA Biotech AG’s NASDAQ Listing and Internationalization Xlife Sciences AG released its Half-Year Report 2025 with focus on VERAXA Biotech AG's NASDAQ listing and internationalization. Operational and financial highlights were shared along with clear priorities for H2 2025 Nasdaq Listing Xlife Sciences AG Internationalization VERAXA Biotech AG Half-Year Report 2025
BRIEF published on 07/17/2025 at 07:05, 8 months 7 days ago VERAXA Biotech AG progresse vers la cotation au NASDAQ grâce au dépôt du formulaire F-4 Cotation Au Nasdaq VERAXA Biotech Regroupement D'entreprises Dépôt Du Formulaire F-4 Thérapeutiques Oncologiques
BRIEF published on 07/17/2025 at 07:05, 8 months 7 days ago VERAXA Biotech AG Advances Toward NASDAQ Listing with Form F-4 Filing Nasdaq Listing Business Combination Oncology Therapeutics VERAXA Biotech Form F-4 Filing
PRESS RELEASE published on 07/17/2025 at 07:00, 8 months 7 days ago Xlife Sciences AG’s Portfolio Company, VERAXA Biotech AG, Takes Key Step Toward NASDAQ Listing with Filing of Form F-4 Xlife Sciences AG's portfolio company VERAXA Biotech AG takes a key step towards NASDAQ listing with the filing of Form F-4, signaling continued momentum and billion-dollar valuation in the public market journey Nasdaq Listing Business Combination Xlife Sciences AG VERAXA Biotech AG Form F-4
Published on 03/24/2026 at 12:05, 32 minutes ago Faraday Copper Continues to Intersect Near-Surface Copper Mineralization at American Eagle and Expands Keel Laterally
Published on 03/24/2026 at 10:10, 2 hours 27 minutes ago BioNxt Enters Commercialization Phase with Global Patent Protection and U.S. Fast Track Strategy for Sublingual Drug Delivery Platform
Published on 03/24/2026 at 08:01, 4 hours 36 minutes ago Star Copper Confirms Copper Creek Mineralization
Published on 03/24/2026 at 07:00, 5 hours 37 minutes ago Panther Minerals Earns In Under Rubidium Ridge Project Option
Published on 03/24/2026 at 07:00, 5 hours 37 minutes ago Panther Completes Acquisition of Rubidium Ridge Project
Published on 03/24/2026 at 12:25, 11 minutes ago Athena Intelligence Launches India Push Amid Rising Cross-Border Corporate Risk
Published on 03/24/2026 at 12:23, 13 minutes ago TURKCIMENTO calls for EU-aligned MRV data recognition under CBAM
Published on 03/24/2026 at 11:59, 37 minutes ago Vienna Soil Dialogue: AGRANA shifts focus to soil as a strategic resource key to Europe’s future
Published on 03/24/2026 at 11:45, 51 minutes ago BIOTRONIK Leaps Forward with Next‑Generation Leadless Pacing
Published on 03/24/2026 at 11:32, 1 hour 4 minutes ago Correction of a release from 24.03.2026 08:00 GMT/BST - official list notice
Published on 03/24/2026 at 10:58, 1 hour 38 minutes ago Statement about the number of shares composing the share capital and the number of voting rights as of February 28, 2026
Published on 03/24/2026 at 10:58, 1 hour 38 minutes ago Déclaration du nombre d'actions composant le capital social et du nombre total de droits de vote au 28 février 2026
Published on 03/24/2026 at 07:45, 4 hours 52 minutes ago François Jackow’s appointment as a Board member will be submitted to the Annual General Meeting on May 7, 2026
Published on 03/24/2026 at 07:45, 4 hours 52 minutes ago La nomination de François Jackow en tant que membre du Conseil d’administration sera soumise à l’Assemblée générale du 7 mai 2026
Published on 03/24/2026 at 07:30, 5 hours 7 minutes ago Gimv secures new EUR 400 million revolving credit facility to support accelerated growth ambitions